Drugs that contain Desvenlafaxine Succinate
1. List of Pristiq drug patents
PRISTIQ's oppositions filed in EPO
PRISTIQ Litigations
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents protects the active chemical substance. Only patent owner can launch products that use this active substance. | ||||
| US6673838 | PF PRISM CV | Succinate salt of O-desmethyl-venlafaxine |
Mar, 2022
(1 year, 3 months ago) | |
| US8269040 | PF PRISM CV | Derivatives of venlafaxine and methods of preparing and using the same |
Jul, 2027
(4 years from now) | |
Do you want to check out PRISTIQ patents from before 2022?
Market Authorisation Date: 29 February, 2008
Treatment: For the approved uses and conditions of use, including depression; Maintenance treatment of major depressive disorder (mdd)
Dosage: TABLET, EXTENDED RELEASE;ORAL
How can I launch a generic of PRISTIQ before it's patent expiration?
More Information on Dosage
PRISTIQ family patents
16
United States
7
European Union
3
Poland
3
Canada
3
Norway
3
Israel
3
Australia
2
Spain
2
Austria
2
Denmark
2
Germany
2
China
2
Argentina
2
Japan
2
New Zealand
2
Cyprus
2
Portugal
2
Hungary
1
Uruguay
1
Panama
1
Hong Kong
1
Czech Republic
1
Brazil
1
EA
1
Honduras
1
Korea, Republic of
1
Guatemala
1
Peru
1
Taiwan
1
Mexico
1
South Africa
1
Slovenia
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic